Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 406 results.
User Information
Export Records
  1. 1.   Tissue-Specific DNA Methylation Changes in CD8+ T Cells During Chronic Simian Immunodeficiency Virus Infection of Infant Rhesus Macaques
  2. Nag,Mukta; Fogle, Jonathan E; Pillay, Santhoshan; Del Prete,Greg; De Paris, Kristina
  3. Viruses. 2024, Nov 27; 16(12):
  1. 2.   Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
  2. Zhang, Ling; Norberg, Scott M; Karimipour, Farrah; Davies, John S; Kuznetsov, Alex; Lassoued, Wiem; Burnett, Daniel; Homan,Philip; Cam, Margaret; Sinkoe, Andrew; Xue, Ping; Gulley, James L; Hinrichs, Christian S
  3. Journal for Immunotherapy of Cancer. 2024, Nov 18; 12(11):
  1. 3.   Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy
  2. Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp,Troy; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto,Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill
  3. International Journal of Cancer. 2024, Oct 31;
  1. 4.   The structure of the IL-11 signalling complex provides insight into receptor variants associated with craniosynostosis
  2. Sentosa, Darlene D; Metcalfe,Riley; Sims, Natalie A; Putoczki, Tracy L; Griffin, Michael D W
  3. The FEBS Journal. 2024, Oct 27;
  1. 5.   Role of physicochemical properties in silica nanoparticle-mediated immunostimulation
  2. Grunberger, Jason William; Newton,Hannah; Donohue,Duncan; Dobrovolskaia,Marina; Ghandehari, Hamidreza
  3. Nanotoxicology. 2024, Oct 26; 1-19.
  1. 6.   In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study
  2. Cedrone,Edward; Ishaq, Abbas; Grabarnik, Emma; Edmondson,Elijah; Skoczen,Sarah; Neun,Barry; Freer, Matthew; Shuttleworth, Siannah; Sviland, Lisbet; Dickinson, Anne; Dobrovolskaia,Marina
  3. Nanomedicine : nanotechnology, biology, and medicine. 2024, Aug 22; 102780.
  1. 7.   Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells
  2. Gutowska, Anna; Sarkis, Sarkis; Rahman, Mohammad Arif; Goldfarbmuren,Kate; Moles, Ramona; Bissa, Massimiliano; Doster, Melvin; Washington-Parks, Robyn; McKinnon, Katherine; Silva de Castro, Isabela; Schifanella, Luca; Franchini, Genoveffa; Pise-Masison, Cynthia A
  3. Pathogens (Basel, Switzerland). 2024, Mar 29; 13(4):
  1. 8.   Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure-Activity Relationship and Mechanistic Insights
  2. Rebolledo, Laura P; Ke, Weina; Cedrone,Edward; Wang, Jian; Majithia, Krishna; Johnson, M Brittany; Dokholyan, Nikolay V; Dobrovolskaia,Marina; Afonin, Kirill A
  3. ACS Applied Materials & Interfaces. 2024, Feb 12;
  1. 9.   Live Imaging and Analysis of Meiotic Cytokinesis in Drosophila Testes
  2. Kunduri,Govind; Acharya,Jairaj
  3. Bio-Protocol. 2024, Jan 20; 14(2): e4918.
  1. 10.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 11.   Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model
  2. Liu, David X; Pahar, Bapi; Cooper, Timothy K; Perry, Donna L; Xu, Huanbin; Huzella, Louis M; Adams, Ricky D; Hischak, Amanda M W; Hart, Randy J; Bernbaum, Rebecca; Rivera, Deja; Anthony, Scott; St Claire, Marisa; Byrum, Russell; Cooper, Kurt; Reeder, Rebecca; Kurtz, Jonathan; Hadley, Kyra; Wada, Jiro; Crozier,Ian; Worwa, Gabriella; Bennett, Richard S; Warren, Travis; Holbrook, Michael R; Schmaljohn, Connie S; Hensley, Lisa E
  3. The Journal of Infectious Diseases. 2023, Jun 04;
  1. 12.   Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles
  2. Newton,Hannah; Radwan, Yasmine; Xu,Jie; Clogston,Jeffrey; Dobrovolskaia,Marina; Afonin, Kirill A
  3. Molecules (Basel, Switzerland). 2023, Jun 01; 28(11):
  1. 13.   CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
  2. Jess, Jennifer; Yates, Bonnie; Dulau-Florea, Alina; Parker, Kevin; Inglefield,Jon; Lichtenstein, Dan; Schischlik, Fiorella; Ongkeko, Martin; Wang,Yanyu; Shahani, Shilpa; Cullinane, Ann; Smith, Hannah; Kane, Eli; Little, Lauren; Chen, Dong; Fry, Terry J; Shalabi, Haneen; Wang, Hao-Wei; Satpathy, Ansuman; Lozier, Jay; Shah, Nirali N
  3. Journal for Immunotherapy of Cancer. 2023, Jun; 11(6):
  1. 14.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 15.   IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium
  2. Andrews, Caroline; McLean, Mairi H; Hixon,Julie; Pontejo, Sergio M; Starr, Tregei; Malo, Courtney; Cam, Margaret; Ridnour, Lisa; Hickman, Heather; Steele-Mortimer, Olivia; Wink,David; Young,Howard; McVicar,Daniel; Li,Wenqing; Durum,Scott
  3. Frontiers in Immunology. 2023, Apr 20; 14: 1021824.
  1. 16.   A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions
  2. Zhou, Ting; Yuan, Constance M; Lurain, Kathryn; Rous, Clarissa; Weaver, Linda; Raffeld, Mark; Stetler-Stevenson, Maryalice; Uldrick, Thomas S; Filie, Armando C; Pittaluga, Stefania; Jaffe, Elaine S; Marshall, Vickie; Moore,Kyle; Whitby,Denise; Ramaswami, Ramya; Yarchoan, Robert; Wang, Hao-Wei
  3. British Journal of Haematology. 2022, Oct 20;
  1. 17.   RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19
  2. Wick, Katherine D; Siegel, Lianne; Neaton, James D; Oldmixon, Cathryn; Lundgren, Jens; Dewar, Robin L; Lane, H Clifford; Thompson, B Taylor; Matthay, Michael A
  3. JCI Insight. 2022, Mar 17; 7(9):
  1. 18.   Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model
  2. Brice, Daniel P; Murray, Graeme I; Wilson, Heather M; Porter, Ross J; Berry, Susan; Durum,Scott; McLean, Mairi H
  3. Biology. 2022, Mar 11; 11(3):
  1. 19.   Neurotoxicity Following CD19/CD28 zeta CAR T-Cells in Children and Young Adults with B-Cell Malignancies
  2. Shalabi, Haneen; Martin, Staci; Yates, Bonnie; Wolters, Pamela L; Kaplan, Claire; Smith, Hannah; Sesi, Christopher R; Jess, Jennifer; Tamula,Mary Anne; Struemph,Kari; Delbrook, Cindy P; Khan, Omar I; Mackall, Crystal L; Lee, Daniel W; Shah, Nirali N
  3. Neuro-Oncology. 2022, Feb 11;
  1. 20.   Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
  2. Bergamaschi, Cristina; Pagoni, Maria; Rosati,Margherita; Angel, Matthew; Tzannou, Ifigeneia; Vlachou, Margarita; Darmani, Ismini; Ullah,Amirah; Bear,Jenifer; Devasundaram,Santhi; Burns,Robert; Baltadakis, Ioannis; Gigantes, Stavros; Dimopoulos, Meletios-Athanasios; Pavlakis,George; Terpos, Evangelos; Felber,Barbara
  3. Frontiers in Immunology. 2022 13: 899972.
  1. 21.   An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
  2. Holley,Claire; Cedrone,Edward; Donohue,Duncan; Neun,Barry; Verthelyi, Daniela; Pang, Eric S.; Dobrovolskaia, Marina A.
  3. Molecules. 2021, Dec; 26(24):
  1. 22.   Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  2. Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin,Antonio; Bergamaschi,Cristina; Felber,Barbara; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 23.   IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
  2. Harper, Taylor A.; Bacot, Silvia M.; Fennell, Christie Jane; Matthews,Rebecca; Zhu, Christina; Yue, Peng; Benton, Alexander; Friedman, Devira; Akue, Adovi; KuKuruga, Mark A.; Lee, Shiowjen; Wang, Tao; Feldman, Gerald M.
  3. International Journal of Molecular Sciences. 2021, Nov; 22(21):
  1. 24.   Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B-1 as a Risk Factor for HIV Transmission and Pathogenesis
  2. Madeen,Erin; Maldarelli,Frank; Groopman, John D.
  3. Pathogens. 2021, Sep 23; 10(10):
  1. 25.   Systemic IL-15, IFN-?, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
  2. Bergamaschi,Cristina; Terpos, Evangelos; Rosati,Margherita; Angel,Matthew; Bear,Jenifer; Stellas,Dimitris; Karaliota,Sevasti; Apostolakou, Filia; Bagratuni, Tina; Patseas, Dimitris; Gumeni, Sentiljana; Trougakos, Ioannis P; Dimopoulos, Meletios A; Felber,Barbara; Pavlakis,George
  3. Cell reports. 2021, Aug 10; 36(6): 109504.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel